210 related articles for article (PubMed ID: 22282643)
21. Evaluation of applied cases of thrombolytic therapy against ultra-acute ischemic stroke. Using the Japanese Standard Stroke Registry Database.
Shiotsuki H; Ogushi Y; Fushimi K; Kobayashi S;
Tokai J Exp Clin Med; 2005 Apr; 30(1):49-62. PubMed ID: 15952299
[TBL] [Abstract][Full Text] [Related]
22. The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis.
Sobesky J; Frackowiak M; Zaro Weber O; Hahn M; Möller-Hartmann W; Rudolf J; Neveling M; Grond M; Schmulling S; Jacobs A; Heiss WD
Cerebrovasc Dis; 2007; 24(1):56-65. PubMed ID: 17519545
[TBL] [Abstract][Full Text] [Related]
23. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
[TBL] [Abstract][Full Text] [Related]
24. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
Ning M; Furie KL; Koroshetz WJ; Lee H; Barron M; Lederer M; Wang X; Zhu M; Sorensen AG; Lo EH; Kelly PJ
Neurology; 2006 May; 66(10):1550-5. PubMed ID: 16717217
[TBL] [Abstract][Full Text] [Related]
25. Safety and outcome after thrombolysis in stroke patients with mild symptoms.
Köhrmann M; Nowe T; Huttner HB; Engelhorn T; Struffert T; Kollmar R; Saake M; Doerfler A; Schwab S; Schellinger PD
Cerebrovasc Dis; 2009; 27(2):160-6. PubMed ID: 19092237
[TBL] [Abstract][Full Text] [Related]
26. Thrombolysis at 3-4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry.
Shobha N; Buchan AM; Hill MD;
Cerebrovasc Dis; 2011; 31(3):223-8. PubMed ID: 21178345
[TBL] [Abstract][Full Text] [Related]
27. Acute stroke management in the elderly.
Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
[TBL] [Abstract][Full Text] [Related]
28. Intra-arterial thrombolysis for acute ischemic stroke in octogenarians.
Mono ML; Romagna L; Jung S; Arnold M; Galimanis A; Fischer U; Kohler A; Ballinari P; Brekenfeld C; Gralla J; Schroth G; Mattle HP; Nedeltchev K
Cerebrovasc Dis; 2012; 33(2):116-22. PubMed ID: 22179504
[TBL] [Abstract][Full Text] [Related]
29. Race/Ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy.
Mehta RH; Cox M; Smith EE; Xian Y; Bhatt DL; Fonarow GC; Peterson ED;
Stroke; 2014 Aug; 45(8):2263-9. PubMed ID: 25070958
[TBL] [Abstract][Full Text] [Related]
30. Cerebral microbleeds on T2*-weighted images and hemorrhagic transformation after antithrombotic therapies for ischemic stroke.
Takahashi W; Moriya Y; Mizuma A; Uesugi T; Ohnuki Y; Takizawa S
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e528-32. PubMed ID: 23830955
[TBL] [Abstract][Full Text] [Related]
31. [Intravenous thrombolytic treatment in acute ischemic stroke: initial results in the Complejo Hospitalario Universitario de Albacete].
García-García J; Gracia-Gil J; Sopelana-Garay D; Ayo-Martín O; Vadillo-Bermejo A; Touza B; Peñalver-Pardines C; Zorita MD; Segura T
Rev Neurol; 2008 Jan 1-15; 46(1):7-12. PubMed ID: 18214820
[TBL] [Abstract][Full Text] [Related]
32. Lipid profiles and outcome in patients treated by intravenous thrombolysis for cerebral ischemia.
Nardi K; Engelter S; Strbian D; Sarikaya H; Arnold M; Casoni F; Ford GA; Cordonnier C; Lyrer P; Bordet R; Soinne L; Gensicke H; Duriez P; Baumgartner RW; Tatlisumak T; Leys D;
Neurology; 2012 Sep; 79(11):1101-8. PubMed ID: 22843281
[TBL] [Abstract][Full Text] [Related]
33. MRI-based ultrafast protocol thrombolysis with rt-PA for acute ischemia stroke in 12-hour time window.
Li YH; Li MH; Zhao JG; Wang W
J Neuroimaging; 2011 Oct; 21(4):332-9. PubMed ID: 21121996
[TBL] [Abstract][Full Text] [Related]
34. Antiplatelet therapy in combination with rt-PA thrombolysis in ischemic stroke (ARTIS): rationale and design of a randomized controlled trial.
Zinkstok SM; Vermeulen M; Stam J; de Haan RJ; Roos YB
Cerebrovasc Dis; 2010; 29(1):79-81. PubMed ID: 19907167
[TBL] [Abstract][Full Text] [Related]
35. Endogenous activated protein C predicts hemorrhagic transformation and mortality after tissue plasminogen activator treatment in stroke patients.
Mendioroz M; Fernández-Cadenas I; Alvarez-Sabín J; Rosell A; Quiroga D; Cuadrado E; Delgado P; Rubiera M; Ribó M; Molina C; Montaner J
Cerebrovasc Dis; 2009; 28(2):143-50. PubMed ID: 19546541
[TBL] [Abstract][Full Text] [Related]
36. Influence of differences in case mix on the better outcome of smokers after intravenous thrombolysis for acute cerebral ischemia.
Moulin S; Padjen-Bogosavljevic V; Marichal A; Cordonnier C; Jovanovic DR; Gautier S; Hénon H; Beslac-Bumbasirevic L; Bordet R; Leys D
Eur Neurol; 2012; 67(3):178-83. PubMed ID: 22286144
[TBL] [Abstract][Full Text] [Related]
37. A higher body temperature is associated with haemorrhagic transformation in patients with acute stroke untreated with recombinant tissue-type plasminogen activator (rtPA).
Leira R; Sobrino T; Blanco M; Campos F; Rodríguez-Yáñez M; Castellanos M; Moldes O; Millán M; Dávalos A; Castillo J
Clin Sci (Lond); 2012 Feb; 122(3):113-9. PubMed ID: 21861843
[TBL] [Abstract][Full Text] [Related]
38. Thrombolytic therapy for acute ischemic stroke: risks vs benefits.
Lindbloom EJ
J Fam Pract; 2003 Oct; 52(10):757, 761. PubMed ID: 14529595
[No Abstract] [Full Text] [Related]
39. Arterial occlusion sites on magnetic resonance angiography influence the efficacy of intravenous low-dose (0.6 mg/kg) alteplase therapy for ischaemic stroke.
Nakashima T; Toyoda K; Koga M; Matsuoka H; Nagatsuka K; Takada T; Naritomi H; Minematsu K
Int J Stroke; 2009 Dec; 4(6):425-31. PubMed ID: 19930051
[TBL] [Abstract][Full Text] [Related]
40. Clinical implication of hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator.
Ho BL; Chen CF; Lin RT; Liu CK; Chao AC
Neurol Sci; 2016 Nov; 37(11):1799-1805. PubMed ID: 27423451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]